Topiramate for Adolescents with Co-Occurring Cannabis Use and Bipolar Disorders
Melissa P. DelBello, M.D., M.S. University of Cincinnati College of Medicine, Cincinnati, OH
Jeffrey Welge, Ph.D. University of Cincinnati, Cincinnati USA
Caleb M. Adler, M.D. University of Cincinnati College of Medicine, Cincinnati, OH
Jennifer Beavers, B.A. University of Cincinnati, Cincinnati USA
Stephen Strakowski, M.D. University of Cincinnati College of Medicine, Cincinnati, OH
Robert Anthenelli, M.D. University of Cincinnati, Cincinnati USA

Developmental Differences in Preschoolers with Bipolar I Disorder
Robert A. Kowatch, M.D., Ph.D. Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Sergio V. Delgado, M.D. Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Erin Monroe, A.P.R.N. Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Early Psychosocial Intervention for Youth At-Risk for Bipolar Disorder
David J. Miklowitz, Ph.D. Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, Los Angeles, CA
Kiki D. Chang, M.D. Stanford University School of Medicine, Palo Alto, CA

Tolerability and Efficacy of Adjunctive Lamotrigine in Youth with Bipolar I Disorder: Preliminary Findings From the Open-Label Phase
Kiki D. Chang, M.D. Stanford University School of Medicine, Palo Alto, CA
Vicki Foster, M.P.H. GlaxoSmithKline, Raleigh, NC
Sherrie Li, B.A. Stanford University School of Medicine, Stanford, CA
Anne Hammer, B.S. GlaxoSmithKline, NC
Joseph P. Horrigan, M.D. GlaxoSmithKline, Durham, NC